AU Patent

AU2008360070B2 — Tablet manufacturing method

Assigned to Bomac Research Ltd · Expires 2015-04-30 · 11y expired

What this patent protects

A method of manufacturing a tablet formulated for administration to an animal containing at least one macrocyclic lactone compound and at least one additional compound with anthelmintic activity by the steps of: (a) dissolving the macrocyclic lactone compound or compounds in at l…

USPTO Abstract

A method of manufacturing a tablet formulated for administration to an animal containing at least one macrocyclic lactone compound and at least one additional compound with anthelmintic activity by the steps of: (a) dissolving the macrocyclic lactone compound or compounds in at least one organic solvent; (b) combining the mixture of step (a) with at least one organic co-solvent; (c) combining the mixture of step (b) with: i. at least one additional compound with anthelmintic activity; ii. at least one binder compound; iii. at least one filler / bulking agent compound; and, (d) drying the mixture of step (c).

Drugs covered by this patent

Patent Metadata

Patent number
AU2008360070B2
Jurisdiction
AU
Classification
—
Expires
2015-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Bomac Research Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.